Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Equitilink was a prominent Australian investment management firm founded in 1981 by Laurence Freedman and Brian Sherman. While not a biotechnology or life sciences company itself, it played a significant role in the Australian financial landscape and was known for managing a variety of investment funds, including those with international exposure. The company gained notoriety for its aggressive marketing and successful growth during the 1980s and 1990s. In 2000, Equitilink was acquired by Aberdeen Asset Management, marking the end of its independent operations. The founders subsequently became well-known philanthropists and investors in various sectors, including technology and environmental causes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Equitilink.